Anna Turetsky
Principal and Venture Investments @ The Mark Foundation for Cancer Research
Boston, United States
Anna Turetsky is a seed investor at The Mark Foundation for Cancer Research in Boston focused on Biopharma and Health Care. Anna Turetsky is based out of New York, New York, and is the General Partner of PxB Fund of OUP (Osage University Partners). Anna previously worked at Vicinitas Therapeutics as a Board Observer. Anna Turetsky attended University of Pennsylvania.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Anna Turetsky invests in
Stages Anna Turetsky invests in
Countries Anna Turetsky invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biopharma 1 (33%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
- Biotechnology 1 (33%)
- Pharmaceutical 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Funding Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Interius BioTherapeutics is a biopharmaceutical company that targets cancer. The company spun out the University of Pennsylvania and is targeting cancer. | $76M / Series A / May 18, 2021 | ||
| Interius BioTherapeutics is a biopharmaceutical company that targets cancer. The company spun out the University of Pennsylvania and is targeting cancer. | $5.5M / Seed / Mar 13, 2020 | ||
| See all 3 investments → | |||
Co-Investors
About The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anna Turetsky
Principal and Venture Investments
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Anna Turetsky invest in?
Anna Turetsky invests primarily in Biopharma, Health Care and Therapeutics startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Anna Turetsky?
Public channels for Anna Turetsky include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Anna Turetsky last invest?
The most recent investment recorded for Anna Turetsky closed in May 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
